Workflow
Rela Solens
icon
Search documents
Zoetis Inc. (ZTS) Could Launch First Long-Acting Anti-NGF Therapy for Cats in Q4 2025
Yahoo Finance· 2025-10-01 17:54
We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Zoetis Inc. is one of them. Zoetis Inc. (NYSE:ZTS), a global leader in animal health, reported solid second-quarter 2025 results with revenue rising 4% year-over-year to $2.5 billion and net income up 15% to $718 million. Growth was driven by an 8% increase in companion animal product sales, led by flagship products such as Simparica Trio for parasite prevention and pain and dermatology treatments, including Rela Sol ...